Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies.

[1]  Gilean McVean,et al.  Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia , 2013, Nature Genetics.

[2]  J. Perin,et al.  Reduced Susceptibility of Plasmodium falciparum to Artesunate in Southern Myanmar , 2013, PloS one.

[3]  Juliana M. Sá,et al.  Plasmodium falciparum Clearance Rates in Response to Artesunate in Malian Children With Malaria: Effect of Acquired Immunity , 2013, The Journal of infectious diseases.

[4]  L. Tilley,et al.  Altered temporal response of malaria parasites determines differential sensitivity to artemisinin , 2013, Proceedings of the National Academy of Sciences.

[5]  C. Amaratunga,et al.  Slow parasite clearance rates in response to artemether in patients with severe malaria. , 2013, The Lancet. Infectious diseases.

[6]  Joana C. Silva,et al.  Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia , 2012, Proceedings of the National Academy of Sciences.

[7]  Saorin Kim,et al.  Reduced Artemisinin Susceptibility of Plasmodium falciparum Ring Stages in Western Cambodia , 2012, Antimicrobial Agents and Chemotherapy.

[8]  K. Silamut,et al.  Effect of High-Dose or Split-Dose Artesunate on Parasite Clearance in Artemisinin-Resistant Falciparum Malaria , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  X. Su,et al.  Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. , 2012, The Lancet. Infectious diseases.

[10]  C. Dolecek,et al.  In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam , 2012, Malaria Journal.

[11]  X. Su,et al.  Mechanisms of in vitro resistance to dihydroartemisinin in Plasmodium falciparum , 2012, Molecular microbiology.

[12]  O. Doumbo,et al.  No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali. , 2012, The American journal of tropical medicine and hygiene.

[13]  F. Nosten,et al.  Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study , 2012, The Lancet.

[14]  M. J. Friedrich.  Artemisinin-Resistant Malaria , 2012 .

[15]  K. Stepniewska,et al.  Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator , 2011, Malaria Journal.

[16]  M. Gatton,et al.  Phenotypic Changes in Artemisinin-Resistant Plasmodium falciparum Lines In Vitro: Evidence for Decreased Sensitivity to Dormancy and Growth Inhibition , 2011, Antimicrobial Agents and Chemotherapy.

[17]  Hervé Le Nagard,et al.  Online analysis of in vitro resistance to antimalarial drugs through nonlinear regression , 2011, Comput. Methods Programs Biomed..

[18]  P. Siba,et al.  A new high-throughput method for simultaneous detection of drug resistance associated mutations in Plasmodium vivax dhfr, dhps and mdr1 genes , 2011, Malaria Journal.

[19]  N. White.  The parasite clearance curve , 2011, Malaria Journal.

[20]  T. Wellems,et al.  The threat of artemisinin-resistant malaria. , 2011, The New England journal of medicine.

[21]  Bruce Russell,et al.  Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcription , 2011, BMC Genomics.

[22]  Richard J. Maude,et al.  Intrahost modeling of artemisinin resistance in Plasmodium falciparum , 2010, Proceedings of the National Academy of Sciences.

[23]  M. Enserink.  Malaria's drug miracle in danger. , 2010, Science.

[24]  X. Su,et al.  Increased Tolerance to Artemisinin in Plasmodium falciparum Is Mediated by a Quiescence Mechanism , 2010, Antimicrobial Agents and Chemotherapy.

[25]  K. Silamut,et al.  Artemisinin resistance in Plasmodium falciparum malaria. , 2009, The New England journal of medicine.

[26]  M. Fukuda,et al.  Evidence of artemisinin-resistant malaria in western Cambodia. , 2008, The New England journal of medicine.

[27]  Pardis C Sabeti,et al.  A general SNP-based molecular barcode for Plasmodium falciparum identification and tracking , 2008, Malaria Journal.

[28]  I. Mueller,et al.  A Multiplex Ligase Detection Reaction-Fluorescent Microsphere Assay for Simultaneous Detection of Single Nucleotide Polymorphisms Associated with Plasmodium falciparum Drug Resistance , 2006, Journal of Clinical Microbiology.

[29]  J. Le bras,et al.  Assessment of the Drug Susceptibility of Plasmodium falciparum Clinical Isolates from Africa by Using a Plasmodium Lactate Dehydrogenase Immunodetection Assay and an Inhibitory Maximum Effect Model for Precise Measurement of the 50-Percent Inhibitory Concentration , 2006, Antimicrobial Agents and Chemotherapy.

[30]  P. Zimmerman,et al.  Development of a Multiplex PCR-Ligase Detection Reaction Assay for Diagnosis of Infection by the Four Parasite Species Causing Malaria in Humans , 2004, Journal of Clinical Microbiology.

[31]  K. Silamut,et al.  Relation of the stage of parasite development in the peripheral blood to prognosis in severe falciparum malaria. , 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[32]  P. Phillips-Howard,et al.  The epidemiology of drug-resistant malaria. , 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[33]  J. Haynes,et al.  Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique , 1979, Antimicrobial Agents and Chemotherapy.

[34]  Ian H. Cheeseman.  Malaria A Major Genome Region Underlying Artemisinin Resistance in , 2012 .

[35]  M. Wahlgren,et al.  METHODS IN MALARIA RESEARCH , 2008 .